REPL (REPL) Stock Price & Analysis
REPL (REPL) fell 1.64% to USD 15.04 as of September 8, 2026 at 06:20 UTC, according to Nexqual real-time market data.
REPL last closed at USD 15.04; the session ranged USD 14.8–15.33 on volume of 910,229 shares. Market capitalization is —, with a 52-week range of USD 1.5–16.33 (NMS). Source: Nexqual, September 8, 2026 at 06:20 UTC.
Key Statistics (as of September 8, 2026 at 06:20 UTC)
| Price | USD 15.04 |
|---|---|
| Change | ▼ 1.64% (down) |
| Previous Close | USD 15.04 |
| Open | USD 15.04 |
| Day Range | USD 14.8 – 15.33 |
| 52-Week Range | USD 1.5 – 16.33 |
| Volume | 910,229 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (REPL)
Nexqual's technical model rates REPL "BUY" based on 4 bullish and 1 bearish signals across 128 daily candles, as of September 8, 2026 at 06:20 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 54.99 (neutral) |
| vs SMA50 | Above (USD 12.25) |
| MACD | 1.03 (positive) |
From REPL's Latest SEC 10-K Filing (filed 2026-06-29)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SRRK | Scholar Rock Holding Corporatio | USD 55.33 | ▼ 1.37% |
| CRNX | Crinetics Pharmaceuticals, Inc. | USD 84.95 | ▲ 0% |
| SNDX | Syndax Pharmaceuticals, Inc. | USD 20.56 | ▼ 1.06% |
| STOK | Stoke Therapeutics, Inc. | USD 29.81 | ▼ 2.26% |
| KURA | Kura Oncology, Inc. | USD 13.25 | ▲ 1.07% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:20 UTC. This page is informational and not investment advice.